Rapamycin tops NIH review of anti-aging drugs
UT Health San Antonio - 28-Aug-2025Rapamycin extended mouse lifespan by up to 28%, even when given in mid or late life, review finds
Join the club for FREE to access the whole archive and other member benefits.
Rapamycin extended mouse lifespan by up to 28%, even when given in mid or late life, review finds
Youthful brains and immune systems are key to longer life
This pathway could guide human anti-ageing therapies
Therapies like exercise, drugs, and mitochondrial transfer offer hope
This shows systemic factors drive skin rejuvenation
Scientists are testing medicines, diets, and lifestyle changes to keep immunity strong
Review finds only modest, inconsistent lifespan gains from most longevity compounds in mammals
Young blood and AdipoRon restore retinal function by activating anti-aging pathways in old mice
New AI system drafts discharge papers, cutting delays and easing hospital backlogs
Four-year trial links vitamin D supplements to reduced DNA telomere shortening
Jab targeting KRAS mutation kept some patients cancer-free for over 15 months
Gordon Sanghera to leave after 20 years as takeover interest grows in UK DNA sequencing firm
New facial-recognition apps aim to spot disease, ageing, and health risks from a single photo
15-year Swedish study finds plant-rich diets may delay age-related diseases and boost longevity
Experts say AI, robotics, and genetics could make “practical immortality” possible
New funding will help expand OneSkin’s reach and target ageing at the cellular level
Semaglutide study reveals slowed aging in key organs and up to five years’ brain age reversal
Scientists explore snail eye regrowth to uncover clues for repairing human vision
Biological age dropped by over 3 years, showing systemic rejuvenation and fertility restoration
Cartilage regeneration and reduced aging effects were observed in lab and animal studies
Study finds eggs maintain mitochondrial DNA integrity, unlike other body cells that age
Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
Results stayed consistent across gender, age, and health status
The treatment may help people with diseases like Parkinson’s and heart problems